CERO

Cero Therapeutics Holdings I

-$1.6M

Net Activity

Institutions Holding

11

Popularity Rank

#9201

Avg Weight

0.00%

Total Value

$798.7K

Ownership Trend

11 institutions currently hold CERO, with 11 net buyers and 0 net sellers this quarter.

Institutional Moves

Institutional Moves (Q3 2025)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

0

Net Buying Institutions

11

Key Holders

View all 11 holding institutions

Quarterly Activity

Recent Activity

+$798.7K

Total Buy Value

$0.0

Total Sell Value

New buy11
Trim0
Add0
Sold out0

11

Net Buyers

0

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding CERO THERAPEUTICS HOLDINGS I (CERO)?
Major stakeholders currently include Parallel Advisors, LLC ($615.9K), ARCH Venture Management, LLC ($114.0K), Susquehanna International Group, LLP ($52.1K). Based on the latest 13F filings, there are a total of 11 tracked investment funds and institutions maintaining positions in CERO.
What is the overall institutional sentiment toward CERO recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $1.6M, driven by 11 managers accumulating shares while 0 reduced their exposure.
Which institutions have been selling or reducing their CERO positions?
In the latest period, no tracked funds trimmed or exited their positions in CERO.
Are there any notable investors adding CERO to their portfolios?
Yes, buying activity remains notable. 11 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $798.7K.

Related Stocks